about
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The...
Read More
23.02
-1.35
(-5.54%)
1.2M
XNAS Volume
XNAS 28 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
uniQure NV Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..